Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Danielle Bancroft (Chair)Best Practice Software
Melva PetersJenaker Consulting
Margaret WeikerNCPDP
Stephen ChuAustralian Digital Health Agency (ADHA)
Peter SergentHL7 New Zealand
Brad Wise
Corey SpearsMitre
Scott RobertsonKaiser Permanente
John Hatem Independent Consultant

Christof GessnerHL7 Germany
Jean DuteauDuteau Design
Shelly SpiroPharmacy HIT Collaborative
Dave HillMITRE
Frank McKinneyPOCP

Agenda Items and Notes

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

Discussion of MedicationKnowledge changes (Jean Duteau)

Catalog Updates (John Hatem)

  • - no meeting last week; next meeting is Nov 19th

Workflow Update (John Hatem) 

  • - short meeting today. no pharmacy issues discussed
    • I had asked a question about how many approved changes to the patterns have not been updated in the patterns - the answer is 17 items

Healthcare Product Update (John Hatem)

  • -  from an email exchange with Hans B, his answers to our question are below: 
  1. What element in Device should we use to specify the port/lumen?
    1. answer: use Device.type
  2. What element in Device should we use to specify the triple lumen catheter?
    1. answer: use Device.type
  3. If we needed to specify the gauge of the lumen/port, which element in Device would we use?  and which resource should we do this in?  the Device where the port/lumen is specified, or in the parent Device?
    1. answer: use

NCPDP Updates (NCPDP Members)

  • No updates. Most Task Group Meetings will resume their normal meeting schedule the week of November 15th.

Global Supply Chain Project (Scott)

Medication List Guidance project (John)

  • - no updates this past week


Pharmacy Templates

  • waiting for requirements from Christof and then will decide on next steps for new version

PDex Formulary (Corey)

  • FHIR-33188 - support of bulk data
    • DaVinci has asked that guidance be added to support bulk data 
    • Need to clarify if the original PSS included this use case
    • will consider for future use and confirm that the original PSS supports the use case for Bulk Data
      • will be removed from the IG for this cycle
  • 2 week review period needed 

FHIR (Group)

BR&R managed resources review

New Resource - FormularyItem

  • Melva to reach out to Jean about updating the PSS

Preparation for Normative

  • Melva to work with John about 

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

Any Other Business

Next meeting

  • November 22, 2021
  • November 29, 2021
    • Formulary IG approval to go to ballot